Open AccessEFFECTS OF WHOLE FRUIT EXTRACT OF ELAEAGNUS ANGUSTIFOLIA L. ON GLIOBLASTOMA CELL LINES
Author(s) -
Samaneh Arab,
Marjan Bahraminasab,
Alireza Yazdani,
Anna Abdolshahi
Publication year - 2021
Publication title -
journal of microbiology, biotechnology and food sciences
Language(s) - English
Resource type - Journals
ISSN - 1338-5178
DOI - 10.55251/jmbfs.4314
Subject(s) - phytochemical , cytotoxicity , rutin , apigenin , traditional medicine , mtt assay , chemistry , viability assay , maceration (sewage) , flavonoid , high performance liquid chromatography , in vitro , pharmacology , biology , antioxidant , biochemistry , chromatography , medicine , materials science , composite material
Elaeagnus. angustifolia L. (EA) is a natural plant food with therapeutic and medicinal properties for treating various diseases such as rheumatoid arthritis and osteoporosis. Since herbal agents are origins of bioactive compounds, they can be applied in complementary treatment protocols. In this study, EA whole fruit extract's cytotoxic effects were investigated on both animal and human glioblastoma cancer cell lines. The extract of whole fruit of EA was obtained by maceration in ethanol. The phytochemical compounds were identified using high-performance liquid chromatography (HPLC). The MTT and LDH assays were performed to evaluate the cytotoxicity effect of the extract and the determination of cell death. Wound-healing assay and colony formation analysis were employed for migration and proliferation evaluation. Based on HPLC analysis, the main flavonoid components of the extract were included rutin and apigenin. The results demonstrated that EA extract at the dose of 125 to 2000 µg/ml and 61.5 to 2000 µg/ml inhibited C6 and U87 cells' viability and induced significant cell cytotoxicity at both 48 and 72 h incubation times. Besides, EA extract significantly inhibited cell migration and colony formation at 250 to 1000 µg/ml concentration. Overall, the results showed that EA extract could inhibit several stages in glioblastoma carcinogenesis in vitro. Therefore, it can be suggested as an anticancer in the clinical treatment approaches of glioblastoma cancer.